… Nanoparticles that are loaded with PLGA and also coated with Tween R 80 show enhanced
… Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain …

… Loperamide-loaded PLGA-PEG-PLGA (PEP) NPs were prepared by a nanoprecipitation …
Tacrine and rivastigmine-loaded polysorbate 80-coated PBCA NPs were applied to healthy …

… % release of the drug from PLGA nanoparticles after about 3 h. … In another study, PLGA NPs
were prepared by solvent … of poly(butylcyanoacrylate) (PBCA) to reduce toxic effects induced …

… In this work, we describe poly(lactic-co-glycolic acid) (PLGA)-based polymeric nanoparticles
loaded with S14. Their preparation, optimization, characterization and in vivo drug release …

… This review focuses on recent developments in nanotechnology-based drug delivery
systems for dementia and related disorders such as Alzheimer’s disease. Recent advances in …

… So, they are biodegradable, with optimal sizes ranging from 100 to 200 nm. … also performed
analysis of rivastigmine-liposome and CPP27 modified rivastigmine-loaded liposome for …

… Shadab et al. prepared NPs of donepezil using PLGA for … These PLGA NPs were prepared
by the solvent emulsification diffusion-… Preparation and characterization of a polymeric (PLGA) …

… PLGA-b-PEG diblock copolymer-based nanoparticles were loaded with the diabetes drug
… The inherent hydrophobic and electrostatic characteristics of nanoparticles are widely …

… and BBB penetration characteristics in the diagnosis of AD [… into the PLGA-curcumin
nanoparticle increased its neuronal … urgent attention include: Optimization and standardization of …

… study of freshly prepared and/or unfixed brain tissues by laser microprobe mass analysis,
neutron … Therefore, rivastigmine-loaded chitosan NPs are a potential treatment option for AD …